Who the mysterious Lizard King might be, how this Psilocybe cubensis strain behaves, why effects vary, and what current psilocybin rules mean for DC, Maryland, and Virginia readers.

DoubleBlind Mag spotlights rising 'pill shaming' in psychedelic spaces. Here’s what it means for people on SSRIs, the early research, and how DMV readers can stay safe.

MKUltra and modern psyops shape how patients judge claims. Here’s how DMV readers can vet medical marijuana delivery, dosing, and safety without falling for propaganda.

From microdosing to mindful presence, a look at how some fathers are weaving psychedelic lessons into parenting—and what DMV families should consider next.

New research suggests festivals and ceremonial settings may nurture similar trauma relief through community and shared meaning—raising practical lessons for DMV readers.

A close look at new research on psychedelics, authoritarian attitudes, and what an April executive action could mean—plus why DMV cannabis rules are a separate lane.

Facing budget shortfalls, Oregon will consolidate psilocybin and medical cannabis oversight and is proposing steep fee hikes. Here’s what’s changing, why it matters, and how DMV readers should read the tea leaves.

Permaculture’s systems thinking offers a grounded framework for psychedelic preparation, safety, and integration—especially for DMV patients and caregivers.

Discover the legal battles, scientific testing disputes, and regulatory developments surrounding the Church of Sacred Synthesis sacrament.

Navigating intense ceremonial connections requires grounded communication, emotional boundaries, and real-world relationship integration.

Filmmaker-novelist Lindsay Kent uses a crime thriller to probe consciousness, identity, and power—showing how fiction can shape real debates in the DMV.

A small primate study reported by DoubleBlind Mag hints ayahuasca may blunt stress-related brain changes linked to isolation—what it does and doesn’t mean for the DMV.

An executive order in Puerto Rico directs health officials to build a pilot program for ibogaine, psilocybin, and MDMA research, with veterans prioritized for potential clinical trial access.

Resilient Pharmaceuticals submits a renewed application for MDMA-assisted PTSD therapy, seeking FDA approval without a fresh Phase 3 trial.

A new biography reveals how fabricated Indigenous lineage created a persistent blueprint for exploitation in the psychedelic underground.

A look at non‑drug “technodelics” like mirrored chambers, strobe light journeys, and full‑body pods—and what early research suggests about benefits, safety, and limits.

Indigenous leaders gather in Spain to redefine entheogen stewardship, reciprocity, and biocultural rights in a landmark international forum.